Inhibition of carnitine biosynthesis by valproic acid in rats—The biochemical mechanism of inhibition
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
The anticonvulsive drug, valproic acid (VPA), inhibits the biosynthesis of carnitine, and may contribute in this way to carnitine deficiency associated with VPA therapy. The conversion of [3H]-butyrobetaine into [3H]-carnitine was determined 60 min following a single intraperitoneal (i.p.) dose of 1.2 mmol/kg VPA in rats. The fraction of radioactivity found in [3H]-carnitine in the liver decreased from 63.2 +/- 1.50% to 39.2 +/- 1.11% (mean +/- SEM). Total carnitine in the liver also decreased, whereas the precursor butyrobetaine increased from 5.01 +/- 0.71 nmol/g to 8.22 +/- 0.82 nmol/g (mean +/- SEM). VPA also exhibited a dramatic effect on the conversion of an unlabeled loading amount of butyrobetaine. The increment in total carnitine caused by butyrobetaine in liver was reduced from 161 +/- 15.4 nmol/g to 53.2 +/- 5.11 nmol/g (mean +/- SEM). These data prove that VPA reduces the flux through butyrobetaine hydroxylase (EC 1.14.11.1.). The drug in vitro, however, did not inhibit the enzyme directly. Searching for the mechanism of action, we found that VPA decreased the level of alpha-ketoglutarate (alpha-KG; a cofactor of butyrobetaine hydroxylase) from 73.5 +/- 2.90 nmol/g to 52.9 +/- 2.2 nmol/g (mean +/- SEM) in the liver. The level of 1-glutamate showed a rather dramatic decrease in the liver. Moreover, alpha-KG proved to have a protective role against VPA in the [3H]-butyrobetaine conversion experiment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, more current evidence suggests that carnitine reserves can be compromised by depletion of essential micronutrients and/or metabolites, such as iron, vitamin C, and ␣-ketoglutarate (26 -31), all of which are required cofactors for carnitine biosynthetic enzymes.”
From Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control (2009) · cites this paper as [31]
Citations
Cites
(1975) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/58.5.1085 · Cited by 19,795
A method for the determination of carnitine in the picomole range
Cederblad, G., & Lindstedt, S. (1972) · Clinica Chimica Acta · doi:10.1016/0009-8981(72)90438-x · Cited by 453
Carnitine metabolism in the fasting rat.
Brass, E. P., & Hoppel, C. L. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40875-1 · Cited by 299
Chalmers, R. A., Roe, C. R., Stacey, T. E., & Hoppel, C. L. (1984) · Pediatric Research · doi:10.1203/00006450-198412000-00021 · Cited by 248
L�scher, W. (1993) · Neurochemical Research · doi:10.1007/bf00967253 · Cited by 156
L-carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia.
Roe, C. R., Millington, D. S., Maltby, D. A., Bohan, T. P., & Hoppel, C. L. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111387 · Cited by 142
Carnitine metabolism and inborn errors
Engel, A. G., & Rebouche, C. J. (1984) · Journal of Inherited Metabolic Disease · doi:10.1007/bf03047372 · Cited by 137
Cofactor Requirements of γ-Butyrobetaine Hydroxylase from Rat Liver
Lindstedt, G., & Lindstedt, S. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62901-1 · Cited by 135
Pivampicillin-promoted excretion of pivaloylcarnitine in humans
Melegh, B., Kerner, J., & BIEBER, L. L. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90318-2 · Cited by 101
Mitochondrial metabolism of valproic acid
Jianxun, L., Norwood, D. L., Mao, L. F., & Schulz, H. (1991) · Biochemistry · doi:10.1021/bi00216a012 · Cited by 95
Research works printed but not linked: 5
- Bohan, 1984, A novel metabolite of valproic acid, Ann Neurol, 16, 394
- Michal, 1974, vol. 4, 1967
- Michal, 1974, 2-Oxoglutarate, vol. 3, 1577
- Michal, 1974, L-glutamate. A., vol. 4, 1705
- Stadtman, 1957, Preparation and assay of acetyl-coenzyme A and other thiol esters; use of hydroxylamine, vol. 3, 931
Cited by
Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A review
Silva, M. F. B., Aires, C. C. P., Luis, P. B. M., Ruiter, J. P. N., IJlst, L., Duran, M., Wanders, R. J. A., & Tavares de Almeida, I. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0841-x · Cited by 382
“Inhibition of carnitine biosynthesis has been reported after a single intraperitoneal dose of VPA in rats (Farkas et al 1996).”
BackgroundNoland, R. C., Koves, T. R., Seiler, S. E., Lum, H., Lust, R. M., Ilkayeva, O., Stevens, R. D., Hegardt, F. G., & Muoio, D. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.032888 · Cited by 317
Carnitine in the treatment of valproic acid-induced toxicity
Lheureux, P. E. R., & Hantson, P. (2009) · Clinical Toxicology · doi:10.1080/15563650902752376 · Cited by 274
“Third, VPA reduces endogenous synthesis of carnitine by blockade of the enzyme γ-butyrobetaine hydroxylase (29).”
Relative Carnitine Deficiency in Autism
Filipek, P. A., Juranek, J., Nguyen, M. T., Cummings, C., & Gargus, J. J. (2004) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-004-5283-1 · Cited by 196
New-Onset Diabetes Mellitus Associated With the Initiation of Quetiapine Treatment
Sobel, M., Jaggers, E. D., & Franz, M. A. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0809f · Cited by 122
Metadata
- Authors
- Farkas, V., Bock, I., Cseko, J., & Sandor, A.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 1996-11
- Volume
- 52
- Issue
- 9
- Pages
- 1429-1433
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2071170489
- Cited by
- 49
- References
- 26
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2019: 4 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2013: 1 · 2012: 2
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Biochemical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- valproic acid, carnitine biosynthesis, carnitine deficiency, alpha-ketoglutarate, liver, enzyme cofactors
- MeSH terms
- Acetyl Coenzyme A, Animals, Anticonvulsants, Betaine, Carnitine, Coenzyme A, Humans, Ketoglutaric Acids, Liver, Male, Valproic Acid, Rats, Wistar, Glutamic Acid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of carnitine biosynthesis by valproic acid in rats—The biochemical mechanism of inhibition. https://app.cochat.ai/papers/10.1016/s0006-2952(96)00507-2
- The paper
- Farkas, V., Bock, I., Cseko, J., & Sandor, A. (1996). Inhibition of carnitine biosynthesis by valproic acid in rats—The biochemical mechanism of inhibition. Biochemical Pharmacology. https://doi.org/10.1016/s0006-2952(96)00507-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.